Pavan Cheruvu insider trades: Sio Gene Therapies (SIOX) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Pavan reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 23, 2021 | SIOX | ↑ Buy | 100,000 | $2.48 | $248K | Direct | Mar 24, 2021 (1d) |
| Jul 8, 2020 | AXGT | ↑ Buy | 37,500 | $2.74 | $103K | Direct | Jul 10, 2020 (2d) |
| Jun 14, 2019 | AXGT | ↑ Buy | 7,500 | $5.21 | $39K | Direct | Jun 17, 2019 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Pavan Cheruvu's insider trades
Pavan Cheruvu is Chief Executive Officer at Sio Gene Therapies (SIOX). Since Jun 14, 2019, Pavan has reported 3 open-market purchases worth $390K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (9 filings), shares returned to the company (3 filings), shares withheld for taxes (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SIOX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.